Discover our diagnostic offer for cystic fibrosis
May is Cystic Fibrosis (CF) Awareness Month. Infections of Nontuberculous mycobacteria (NTM) are more prevalent in individuals with CF, with 20% of CF patients experiencing an NTM infection from 2010 - 2016.
Our range of screening solutions
NTM Elite agar
The American Society for Microbiology & UK Cystic fibrosis Trust recommend to use the NTM Elite agar for the selective recovery of rapid growing mycobacteria from respiratory specimens of cystic fibrosis
- Improve respiratory diagnostics with an accurate detection of NTM
- NTM diagnostics accessible in routine condition with reduced handling steps and confirmatory test
CHROMID® S. aureus Elite agar (SAIDE)
- Accurate and clear identification of S. aureus
- High medical value for respiratory samples of CF patients
CHROMID® P. aeruginosa Agar
- Deliver rapid direct identification of Pseudomonas aeruginosa to contribute to early intervention and better patient management
- High medical value for monitoring cystic fibrosis patients
BCSA Burkholderia cepacia selective agar
- Selective isolation of Burkholderia cepacia.as recommended in current guidelines
